LIVE
 
 
 
 
 
 
 
 
 
 
 
 

Advanced search with filter

15/10/2026
EQS-News: Fresenius SE & Co. KGaA / Key word(s): Personnel Supervisory Board appoints Dr. Marc-Alexander Mahl to the Fresenius Management Board and extends Sara Hennicken’s contract (news with additional features) 15.10.2026 /...
01/10/2026
EQS-News: Fresenius SE & Co. KGaA / Key word(s): Strategic Company Decision Fresenius acquires remaining 45% of mAbxience for up to €750 million, taking full ownership of its biosimilars platform (news with additional...
20/08/2026
EQS-News: Fresenius SE & Co. KGaA / Key word(s): Investment Fresenius raises approximately €300 million through sale of 7.8 million Fresenius Medical Care shares (news with additional features) 20.08.2026 / 18:35 CET/CEST The...
10/08/2026
EQS-News: Fresenius SE & Co. KGaA / Key word(s): Rating Fitch Ratings upgrades outlook for Fresenius SE from stable to positive 10.08.2026 / 14:30 CET/CEST The issuer is solely responsible for the content of this...
06/08/2026
EQS-News: Fresenius SE & Co. KGaA / Key word(s): Miscellaneous/AGM/EGM Fresenius transitions to registered shares – automatic conversion for shareholders 06.08.2026 / 13:00 CET/CEST The issuer is solely responsible for the...
04/08/2026
EQS-News: Fresenius SE & Co. KGaA / Key word(s): Quarter Results #FutureFresenius: Excellent Q2 performance demonstrates structural step-up – Guidance raised 04.08.2026 / 22:03 CET/CEST The issuer is solely responsible for...
04/08/2026
EQS-Ad-hoc: Fresenius SE & Co. KGaA / Key word(s): Forecast / Full year Fresenius SE & Co. KGaA: Fresenius raises its earnings guidance for fiscal year 2026 due to strong operational business performance 04-Aug-2026 / 22:01...
23/07/2026
EQS-News: Fresenius SE & Co. KGaA / Key word(s): Financing/Strategic Company Decision Fresenius establishes venture fund of more than €200 million to drive healthcare innovation 23.07.2026 / 10:00 CET/CEST The issuer is...